Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2025-12-24 @ 5:54 PM
NCT ID:
NCT05351268
Eligibility Criteria:
Inclusion Criteria:
* Pathological diagnosis of malignant tumor of chest, lesion diameter less than 7 cm.
* There is no extensive systemic metastasis or although there is metastasis, the metastasis have been controlled by early treatment.
* No bleeding tendency, anticoagulant therapy and / or antiplatelet coagulation drugs should be stopped for at least 1 week before treatment.
* No serious or uncontrolled underlying diseases (such as severe or uncontrolled hypertension, diabetes, cardiovascular and cerebrovascular diseases and organ dysfunction) are found.
* There is a suitable puncture path, and the therapeutic dose is expected to be achieved.
* KPS \> 70, expected to tolerate puncture / seed implantation, and expected survival time greater than 3 months.
Exclusion Criteria:
* Severe impairment of lung function (such as FEV1 \< 40% predicted value, FVC \< 50% predicted value, DLCO \< 40% predicted value).
* High risk of skin invasion and ulceration at the puncture site before treatment.
* There is a large range of liquefaction and necrosis in the lesion, and the expected seed distribution would be poor.
* Pregnant women, lactating women and mentally ill patients.
* The patient with poor compliance and unable to complete the treatment.
* Other conditions of the researchers who think it is not suitable to participate in this clinical trial.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT05351268
Study Brief:
Protocol Section:
NCT05351268